Craig Hendrix, MD

LG Quality Assurance and Ethics Committee Chair
Craig Hendrix, MD

Contact Information


Dr. Hendrix has 30 years of research experience in the pharmacology of drugs, mostly of antiretroviral drugs for HIV treatment and prevention. His research focuses on development of antiretroviral drugs to prevent HIV infection. His lab also supports numerous HIV pre-exposure prophylaxis development studies from phase I to phase III, largely as leader of the Pharmacology Core Laboratory of both the Microbicide Trial Network and HIV Prevention Trials Network.  Dr. Hendrix’ lab and clinical group have developed novel methods for quantitative assessment of drug concentration in complex biological matrices and in three-dimensional space. In addition, using data derived using these methods, models of drug absorption, distribution, and clearance were developed using pharmacometric methods. His team has also applied these methods to intensively sampled phase I studies as to supporting randomized clinical trials providing a broad context of benchtop and clinical pharmacology research for trainees.  Deeply committed to training, mentoring, and promoting inclusive and supportive research environments, Dr. Hendrix is providing a robust and broad-based research training experience with a rigorous, ethical, and individually-tailored scientific training of young pharmacologists through laboratory and clinical studies. He is the Wellcome Professor and Director, Division of Clinical Pharmacology and Director of the Drug Development Unit in the Division.

KFC Scope